Free Trial

Cronos Group (NASDAQ:CRON) Trading 6.1% Higher - Here's Why

Cronos Group logo with Medical background

Cronos Group Inc. (NASDAQ:CRON - Get Free Report)'s stock price traded up 6.1% on Tuesday . The stock traded as high as $2.26 and last traded at $2.26. 1,015,129 shares changed hands during trading, a decline of 48% from the average session volume of 1,967,656 shares. The stock had previously closed at $2.13.

Cronos Group Trading Up 7.5 %

The company has a market cap of $875.47 million, a PE ratio of -15.27 and a beta of 0.97. The firm's 50-day simple moving average is $2.22 and its two-hundred day simple moving average is $2.39.

Cronos Group (NASDAQ:CRON - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.02) earnings per share for the quarter. Cronos Group had a negative return on equity of 2.06% and a negative net margin of 56.43%. The company had revenue of $27.76 million for the quarter, compared to analysts' expectations of $25.85 million. During the same period in the prior year, the firm posted ($0.02) EPS. As a group, analysts predict that Cronos Group Inc. will post -0.05 EPS for the current year.

Institutional Trading of Cronos Group

Several institutional investors and hedge funds have recently bought and sold shares of CRON. National Bank of Canada FI lifted its stake in Cronos Group by 1,094.4% during the 2nd quarter. National Bank of Canada FI now owns 15,169 shares of the company's stock valued at $35,000 after acquiring an additional 13,899 shares during the period. Toronto Dominion Bank lifted its stake in shares of Cronos Group by 204.8% in the 1st quarter. Toronto Dominion Bank now owns 17,054 shares of the company's stock valued at $45,000 after purchasing an additional 11,459 shares during the period. Cedar Wealth Management LLC acquired a new position in shares of Cronos Group in the 1st quarter valued at $60,000. Headlands Technologies LLC lifted its stake in shares of Cronos Group by 12,309.4% in the 2nd quarter. Headlands Technologies LLC now owns 27,797 shares of the company's stock valued at $65,000 after purchasing an additional 27,573 shares during the period. Finally, Concurrent Investment Advisors LLC acquired a new position in shares of Cronos Group in the 1st quarter valued at $79,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.

About Cronos Group

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

See Also

Should you invest $1,000 in Cronos Group right now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines